Glimfra MV 2 Tablet ER
Glimfra MV 2 Tablet ER
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Ozomet-VG2 Tablet SR
Ozone Pharmaceuticals Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹72
that's 62% off!
About This Medicine
Product description & overview
Glimfra MV 2 Tablet ER: A Combined Approach to Blood Sugar Management
Glimfra MV 2 Tablet ER is a convenient once-daily formulation of three essential medications: Glimepiride, Metformin, and Voglibose. This combination offers comprehensive treatment for type 2 diabetes by addressing multiple aspects of blood sugar regulation.
Glimepiride (2mg) helps to increase insulin secretion from the pancreas, ultimately lowering blood glucose levels. Metformin (500mg) acts on cells within the body, improving sensitivity to insulin and reducing hepatic glucose production. Voglibose (0.2mg) directly inhibits α-glucosidase, slowing down the breakdown of carbohydrates during digestion. This prevents rapid absorption into the bloodstream and contributes to sustained control over postprandial glucose levels.
Glimfra MV 2 Tablet ER provides a simplified approach for managing Type 2 diabetes through targeted action on multiple points in the glucose regulatory pathway.
Disclaimer: This is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting or modifying any medication regimen.
Active composition
Glimepiride 2 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimfra MV 2 Tablet ER.
High Risk
Pregnancy
Glimfra MV 2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimfra MV 2 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimfra MV 2 Tablet ER may be needed. Please consult your doctor. Glimfra MV 2 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimfra MV 2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimfra MV 2 Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimfra MV 2 Tablet ER is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glimfra MV 2 Tablet ER
Products matching your search
Evoxil CV Kid Tablet
Evoxil CV Kid Tablet
Genericart Methylprednisolone 8mg Tablet
Genericart Methylprednisolone 8mg Tablet
Eternex-M 500 Tablet SR
Eternex-M 500 Tablet SR
Esomac 40 Tablet
Esomac 40 Tablet
Glix MR 60 Tablet
Glix MR 60 Tablet
Genericart Nicorandil 5mg Tablet
Genericart Nicorandil 5mg Tablet
Combihale FB Forte DPI Capsule
Combihale FB Forte DPI Capsule
Glucomine Trio Tablet